220 related articles for article (PubMed ID: 22594546)
1. Alternative pathways in the development of diabetic retinopathy: the renin-angiotensin and kallikrein-kinin systems.
Phipps JA; Jobling AI; Greferath U; Fletcher EL; Vessey KA
Clin Exp Optom; 2012 May; 95(3):282-9. PubMed ID: 22594546
[TBL] [Abstract][Full Text] [Related]
2. [Kallikrein-kinin system as a target for diabetic retinopathy treatment].
Iarovaia GA; Neshkova EA; Blokhina TB; Kochergin SA; Vorob'eva IV; Gigineishvili DN
Vestn Oftalmol; 2012; 128(4):78-81. PubMed ID: 22994115
[TBL] [Abstract][Full Text] [Related]
3. The kallikrein-kinin system in diabetic retinopathy: lessons for the kidney.
Phipps JA; Feener EP
Kidney Int; 2008 May; 73(10):1114-9. PubMed ID: 18272958
[TBL] [Abstract][Full Text] [Related]
4. The Role of Plasma Kallikrein-Kinin Pathway in the Development of Diabetic Retinopathy: Pathophysiology and Therapeutic Approaches.
Abdulaal M; Haddad NM; Sun JK; Silva PS
Semin Ophthalmol; 2016; 31(1-2):19-24. PubMed ID: 26959125
[TBL] [Abstract][Full Text] [Related]
5. Four decades of ocular renin-angiotensin and kallikrein-kinin systems (1977-2017).
Igić R
Exp Eye Res; 2018 Jan; 166():74-83. PubMed ID: 28549900
[TBL] [Abstract][Full Text] [Related]
6. The retinal renin-angiotensin system: implications for therapy in diabetic retinopathy.
Sjølie AK; Chaturvedi N
J Hum Hypertens; 2002 Aug; 16 Suppl 3():S42-6. PubMed ID: 12140727
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin and diabetic retinopathy.
Wilkinson-Berka JL
Int J Biochem Cell Biol; 2006; 38(5-6):752-65. PubMed ID: 16165393
[TBL] [Abstract][Full Text] [Related]
8. Role of Tissue Renin-angiotensin System and the Chymase/angiotensin-( 1-12) Axis in the Pathogenesis of Diabetic Retinopathy.
Ola MS; Alhomida AS; Ferrario CM; Ahmad S
Curr Med Chem; 2017; 24(28):3104-3114. PubMed ID: 28403787
[TBL] [Abstract][Full Text] [Related]
9. Targeting the kallikrein-kinin system as a new therapeutic approach to diabetic retinopathy.
Pruneau D; Bélichard P; Sahel JA; Combal JP
Curr Opin Investig Drugs; 2010 May; 11(5):507-14. PubMed ID: 20419596
[TBL] [Abstract][Full Text] [Related]
10. The role of the renal kallikrein-kinin system in diabetic nephropathy.
Riad A; Zhuo JL; Schultheiss HP; Tschöpe C
Curr Opin Nephrol Hypertens; 2007 Jan; 16(1):22-6. PubMed ID: 17143067
[TBL] [Abstract][Full Text] [Related]
11. Prospects for angiotensin receptor blockers in diabetic retinopathy.
Sjølie AK
Diabetes Res Clin Pract; 2007 May; 76 Suppl 1():S31-9. PubMed ID: 17321627
[TBL] [Abstract][Full Text] [Related]
12. The kallikrein-kinin system in diabetic retinopathy.
Bhat M; Pouliot M; Couture R; Vaucher E
Prog Drug Res; 2014; 69():111-43. PubMed ID: 25130041
[TBL] [Abstract][Full Text] [Related]
13. Cross-talk of the renin-angiotensin and kallikrein-kinin systems.
Shen B; El-Dahr SS
Biol Chem; 2006 Feb; 387(2):145-50. PubMed ID: 16497145
[TBL] [Abstract][Full Text] [Related]
14. The renin-angiotensin system and diabetic retinopathy.
Kohner EM
Klin Wochenschr; 1992; 69 Suppl 29():25-7. PubMed ID: 1614187
[TBL] [Abstract][Full Text] [Related]
15. Diabetes and retinal vascular disorders: role of the renin-angiotensin system.
Wilkinson-Berka JL
Expert Rev Mol Med; 2004 Jul; 6(15):1-18. PubMed ID: 15387897
[TBL] [Abstract][Full Text] [Related]
16. Kallikrein-kinin activation by altered vitreous pH: New perspectives for treatment and pathogenesis of diabetic macular edema? : Comment on: Gao BB et al. Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation. Nat Med. 2007 Feb;13(2):181-8.
Zeitz O; Keserü M
Graefes Arch Clin Exp Ophthalmol; 2007 Dec; 245(12):1745-7. PubMed ID: 17823811
[TBL] [Abstract][Full Text] [Related]
17. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].
Marzecka J
Ann Acad Med Stetin; 1996; 42():123-38. PubMed ID: 9199117
[TBL] [Abstract][Full Text] [Related]
18. [Multiple interactions between the kallikrein-kinin and the renin angiotensin systems].
Yoshida H
Nihon Rinsho; 2005 Mar; 63 Suppl 3():437-41. PubMed ID: 15813107
[No Abstract] [Full Text] [Related]
19. Vascular endothelial growth factor gene polymorphisms and vitreous proteome changes in diabetic retinopathy.
Dyer KH; Silva PS; Sun JK
Semin Ophthalmol; 2013; 28(5-6):347-54. PubMed ID: 24138044
[TBL] [Abstract][Full Text] [Related]
20. [The role of the kallikrein-kinin and renin-angiotensin-aldosterone systems in the development of hypertension in glomerulonephritis].
Riabov SI; Kucher AG; Kotovoĭ IuO; Kaiukov IG
Klin Med (Mosk); 1990 Dec; 68(12):22-5. PubMed ID: 2084330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
